Table 4 Top 20 predictors selected from random forest model. The polysomnography parameters are indicated in bold.

From: Transforming electronic health record polysomnographic data into the Observational Medical Outcome Partnership's Common Data Model: a pilot feasibility study

No

Covariate name

Importance

Covariate mean with outcome

Covariate mean with no outcome

1

drug_era group during day -7 through 0 days relative to index: Synthetic antispasmodics, amides with tertiary amines

0.008

0.021

0.001

2

measurement value during day -180 through 0 days relative to index: Triglyceride [Mass/volume] in Serum or Plasma (milligram per deciliter)

0.008

35.158

13.156

3

measurement value during day -180 through 0 days relative to index: Systolic blood pressure (millimeter mercury column)

0.007

43.961

24.646

4

measurement value during day -30 through 0 days relative to index: AHI during right lateral (/h) (per hour)

0.006

11.496

7.281

5

measurement value during day -30 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma (unit per liter)

0.006

5.236

1.530

6

measurement value during day -180 through 0 days relative to index: Diastolic blood pressure (millimeter mercury column)

0.006

25.845

14.697

7

drug_era group during day -7 through 0 days relative to index: tiropramide

0.006

0.021

0.001

8

measurement value during day -180 through 0 days relative to index: AHI during right lateral (/h) (per hour)

0.006

11.496

7.281

9

measurement value during day -180 through 0 days relative to index: Central apnea index (/h) (per hour)

0.006

1.040

0.394

10

measurement value during day -7 through 0 days relative to index: AHI during right lateral (/h) (per hour)

0.005

11.496

7.281

11

measurement value during day -7 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma (unit per liter)

0.005

2.923

0.726

12

measurement value during day -30 through 0 days relative to index: Waking oxygen saturation (%) (percent)

0.005

74.268

84.735

13

measurement value during day -7 through 0 days relative to index: Central apnea index (/h) (per hour)

0.005

1.040

0.394

14

measurement value during day -30 through 0 days relative to index: Central apnea index (/h) (per hour)

0.005

1.040

0.394

15

measurement value during day -7 through 0 days relative to index: Snoring time (min) (minute)

0.005

111.030

100.081

16

measurement value during day -7 through 0 days relative to index: AHI during left lateral (/h) (per hour)

0.004

11.716

7.616

17

measurement value during day -180 through 0 days relative to index: Respiratory arousal (per hour)

0.004

22.177

18.561

18

measurement value during day -7 through 0 days relative to index: Waking oxygen saturation (%) (percent)

0.004

74.268

84.735

19

drug_era group during day -30 through 0 days relative to index: tiropramide

0.004

0.021

0.002

20

drug_era group during day -180 through 0 days relative to index: tiropramide

0.004

0.028

0.004